(Q31157425)

English

Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 August 2017

Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients (English)

1 reference

Europe PubMed Central

22 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Daiqing Gao

1

1 reference

Europe PubMed Central

22 August 2017

Changyou Li

2

1 reference

Europe PubMed Central

22 August 2017

Xihe Xie

3

1 reference

Europe PubMed Central

22 August 2017

Peng Zhao

4

1 reference

Europe PubMed Central

22 August 2017

Xiaofang Wei

5

1 reference

Europe PubMed Central

22 August 2017

Weihong Sun

6

1 reference

Europe PubMed Central

22 August 2017

Hsin-Chen Liu

7

1 reference

Europe PubMed Central

22 August 2017

Aris T Alexandrou

8

1 reference

Europe PubMed Central

22 August 2017

Jennifer Jones

9

1 reference

Europe PubMed Central

22 August 2017

Ronghua Zhao

10

1 reference

Europe PubMed Central

22 August 2017

Jian Jian Li

11

1 reference

Europe PubMed Central

22 August 2017

language of work or name

0 references

publication date

3 April 2014

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

9

1 reference

Europe PubMed Central

22 August 2017

4

1 reference

Europe PubMed Central

22 August 2017

e93886

1 reference

Europe PubMed Central

22 August 2017

copyright license

Creative Commons Attribution 4.0 International

3 April 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Sipuleucel-T for the treatment of advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Recent advances in therapeutic cancer vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Third generation dendritic cell vaccines for tumor immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Therapy of relapsed or refractory non-Hodgkin's lymphoma by antigen specific dendritic cells-activated lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Cytokine-induced killer cells are type II natural killer T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Immunotherapy of distant metastatic disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Exploiting dendritic cells for active immunotherapy of cancer and chronic infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Taking dendritic cells into medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Cell technologies in immunotherapy of cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Effective osteosarcoma cytolysis using cytokine-induced killer cells pre-inoculated with tumor RNA-pulsed dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Exploiting dendritic cells for active immunotherapy of cancer and chronic infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Cytokine-induced Killer Cells: NK-like T Cells with Cytotolytic Specificity against Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

Dendritic cells and the control of immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

21 June 2018

SIDE-EFFECTS OF COMBINED RADIATION AND CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT TUMORS.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

Side effects of therapy: case 3. Gastric cancer after radiotherapy of pediatric Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

Cancer: immune pact with the enemy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

Cellular immunotherapy and autologous transplantation for hematologic malignancy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

In vitro anti-tumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

A natural tapasin isoform lacking exon 3 modifies peptide loading complex function

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0093886

21 January 2018

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974849

31 October 2018

Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24699863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs

1 reference

https://pubmed.ncbi.nlm.nih.gov/24699863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24699863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/24699863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24699863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0093886

1 reference

Europe PubMed Central

22 August 2017

2014PLoSO...993886G

0 references

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31157425&oldid=1862169648"